PMID- 1350613
OWN - NLM
STAT- MEDLINE
DCOM- 19920702
LR  - 20190724
IS  - 0022-3018 (Print)
IS  - 0022-3018 (Linking)
VI  - 180
IP  - 6
DP  - 1992 Jun
TI  - Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
PG  - 345-52; discussion 353-4
AB  - 3,4-Methylenedioxymethamphetamine (MDMA) has been at the center of a debate over 
      its potential benefits as an adjunct to psychotherapy versus its capability for 
      neurotoxic effects and is currently classified as a Schedule 1 drug by the Drug 
      Enforcement Administration (DEA). However, as yet, there is very little 
      methodological data on the subjective experience of the MDMA-induced state or its 
      psychological and behavioral sequelae. The present study was, therefore, designed 
      to obtain this kind of information. Twenty psychiatrists who had taken MDMA 
      previously were evaluated using a semistructured interview. Subjective experience 
      of the actual MDMA-induced state, as well as both short-term (less than 1 week) 
      and relatively longer term (greater than 1 week) sequelae, were examined 
      retrospectively. Side effects, insight gained, pleasure, and intensity of the 
      MDMA experience were evaluated as were the influence of set and setting at the 
      time the MDMA was taken and the dosage utilized. Finally, the authors discuss 
      methodological problems and limitations of a study of this type.
FAU - Liester, M B
AU  - Liester MB
AD  - Department of Psychiatry, University of California, Irvine Medical Center, Orange 
      92668.
FAU - Grob, C S
AU  - Grob CS
FAU - Bravo, G L
AU  - Bravo GL
FAU - Walsh, R N
AU  - Walsh RN
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Nerv Ment Dis
JT  - The Journal of nervous and mental disease
JID - 0375402
RN  - 0 (Designer Drugs)
RN  - 4764-17-4 (3,4-Methylenedioxyamphetamine)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - 3,4-Methylenedioxyamphetamine/adverse effects/*analogs & 
      derivatives/pharmacology/therapeutic use
MH  - Adult
MH  - Combined Modality Therapy
MH  - Designer Drugs/adverse effects/*pharmacology/therapeutic use
MH  - Emotions/drug effects
MH  - Female
MH  - Humans
MH  - Interpersonal Relations
MH  - Male
MH  - Mental Disorders/chemically induced/drug therapy
MH  - Middle Aged
MH  - N-Methyl-3,4-methylenedioxyamphetamine
MH  - Nervous System/drug effects
MH  - Perception/drug effects
MH  - Psychotherapy
MH  - Research Design/standards
MH  - Substance-Related Disorders/*psychology
EDAT- 1992/06/01 00:00
MHDA- 1992/06/01 00:01
CRDT- 1992/06/01 00:00
PHST- 1992/06/01 00:00 [pubmed]
PHST- 1992/06/01 00:01 [medline]
PHST- 1992/06/01 00:00 [entrez]
AID - 10.1097/00005053-199206000-00001 [doi]
PST - ppublish
SO  - J Nerv Ment Dis. 1992 Jun;180(6):345-52; discussion 353-4. doi: 
      10.1097/00005053-199206000-00001.